Literature DB >> 20790751

Five Weeks to Escape the Sleeping-pill Habit.

I Oswald, R G Priest.   

Abstract

Year:  1965        PMID: 20790751      PMCID: PMC1846884          DOI: 10.1136/bmj.2.5470.1093

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  AMPHETAMINE AND PHENMETRAZINE ADDICTION. PHYSIOLOGICAL ABNORMALITIES IN THE ABSTINENCE SYNDROME.

Authors:  I OSWALD; V R THACORE
Journal:  Br Med J       Date:  1963-08-17

2.  [STUDY OF SELECTIVE DEPRIVATION OF THE PARADOXAL SLEEP PHASE IN THE CAT].

Authors:  D JOUVET; P VIMONT; F DELORME; M JOUVET
Journal:  C R Seances Soc Biol Fil       Date:  1964

3.  RESPONSES TO AUDITORY STIMULATION, SLEEP LOSS AND THE EEG STAGES OF SLEEP.

Authors:  H L WILLIAMS; J T HAMMACK; R L DALY; W C DEMENT; A LUBIN
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1964-03

4.  A GENERAL THEORY OF THE GENESIS OF DRUG DEPENDENCE BY INDUCTION OF RECEPTORS.

Authors:  H O COLLIER
Journal:  Nature       Date:  1965-01-09       Impact factor: 49.962

5.  Melancholia and barbiturates: a controlled EEG, body and eye movement study of sleep.

Authors:  I OSWALD; R J BERGER; R A JARAMILLO; K M KEDDIE; P C OLLEY; G B PLUNKETT
Journal:  Br J Psychiatry       Date:  1963-01       Impact factor: 9.319

6.  Effects of sleep deprivation on behaviour, subsequent sleep, and dreaming.

Authors:  R J BERGER; I OSWALD
Journal:  J Ment Sci       Date:  1962-07

7.  The effect of dream deprivation.

Authors:  W DEMENT
Journal:  Science       Date:  1960-06-10       Impact factor: 47.728

8.  Tolerance to some effects of barbiturates.

Authors:  R E BELLEVILLE; H F FRASER
Journal:  J Pharmacol Exp Ther       Date:  1957-08       Impact factor: 4.030

9.  The relation of eye movements during sleep to dream activity: an objective method for the study of dreaming.

Authors:  W DEMENT; N KLEITMAN
Journal:  J Exp Psychol       Date:  1957-05

10.  Chronic barbiturate intoxication: further studies.

Authors:  H F FRASER; H ISBELL; A J EISENMAN; A WIKLER; F T PESCOR
Journal:  AMA Arch Intern Med       Date:  1954-07
View more
  36 in total

1.  Effects of thienodiazepine derivatives on human sleep as compared to those of benzodiazepine derivatives.

Authors:  Y Nakazawa; M Kotorii; M Oshima; S Horikawa; H Tachibana
Journal:  Psychopharmacologia       Date:  1975-10-31

2.  Plasma level studies in psychotropic evaluation.

Authors:  S H Curry
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

3.  The effect of triazolam on the sleep of insomniacs.

Authors:  G Vogel; A Thurmond; P Gibbons; K Edwards; K B Sloan; K Sexton
Journal:  Psychopharmacologia       Date:  1975

Review 4.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 5.  Sleep and hypnotic drugs.

Authors:  M W Johns
Journal:  Drugs       Date:  1975       Impact factor: 9.546

6.  Barbiturate prescribing: psychiatrists' views.

Authors:  B M Barraclough
Journal:  Br Med J       Date:  1976-10-16

7.  A psychophysiological investigation of the long-term effects of clozapine upon sleep patterns of normal young adults.

Authors:  S W Touyz; G S Saayman; T Zabow
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

8.  Effects of dixyrazine and methaqualone on the sleep pattern in normal man.

Authors:  A M Risberg; J Risberg; D Elmqvist; D H Ingvar
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

9.  Benzodiazepine hypnotics remain effective for 24 weeks.

Authors:  I Oswald; C French; K Adam; J Gilham
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-20

10.  Effect of chronic pentobarbital treatment on the sleep patterns of squirrel monkeys.

Authors:  P M Adams; E S Barratt
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.